• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

CDC20 Antibody – Mouse Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS847425

Cyclins, regulatory subunits, which associate with kinases, control many of the important steps in cell cycle progression. The Cdc2 protein kinase (p34Cdc2) exhibits protein kinase activity in vitro and exists in a complex with both cyclin B and a protein… More details

DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Product Name
Cdc20, Monoclonal Antibody
Full Product Name
Anti-Cdc20 Antibody (CDC20/1102)
Product Gene Name
anti-Cdc20 antibody
Product Synonym Names
CDC20; CDC20A; p55CDC; P55CDC-LSB; Cell division cycle protein 20 homolog
Clonality
Monoclonal
Isotype
Mouse IgG1, kappa
Clone Number
CDC20/1102
Host
Mouse
Species Reactivity
Human
Form/Format
Colorless liquid. Supplied in 10mM PBS with 0.05% BSA & 0.05% azide
Purity/Purification
Protein A/G purification
Specificity
Monoclonal Antibody to detect Cdc20 in human samples
Preparation and Storage
Store at -20 degree C
The antibody solution should be gently mixed before use
Shelf life: ~12 months
Molecular Weight
54,723 Da
Chromosome Location
Chromosome: 1; NC_000001.10 (43824626..43828874). Location: 1p34.1
OMIM
603618
3D Structure
ModBase 3D Structure for Q12834
Immunogen
Recombinant human Cdc20 protein
Positive Control
IHC: Human Tonsil, human Gastric Carcinoma

Product Categories/Family for anti-Cdc20 antibody

Immunology; Antibodies & Supporting Tools; Marker Antibodies; Cell Cycle
Applications Tested/Suitable for anti-Cdc20 antibody
Flow Cytometry (FC/FACS), Immunofluorescence (IF), Immunohistochemistry (IHC)
Application Notes for anti-Cdc20 antibody
FC/FACS: 0.5-1ug/1x106 cells in 0.1ml
IF: 0.5-1ug/ml
IHC: 2-4ug/ml for 30 minutes at room temperature

Immunohistochemistry (IHC) of anti-Cdc20 antibody

Mouse Anti-CDC20 Monoclonal Antibody – Cat# MBS847425

Immunohistochemistry (IHC) of anti-Cdc20 antibody

Mouse Anti-CDC20 Monoclonal Antibody, Immunohistochemistry (IHC) – Cat# MBS847425

Other Notes

Small volumes of anti-Cdc20 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Cdc20 purchase

MBS847425 is an antibody targeting Cdc20. Also known as Anti-Cdc20 Antibody (CDC20/1102). Reactive in Human. Host: Mouse.

Additional Details

NCBI/Uniprot data below describe general gene information for Cdc20. It may not necessarily be applicable to this product.

NCBI GI #
118402582
NCBI GeneID
991
NCBI Accession #
NP_001246.2
UniProt Primary Accession #
Q12834
UniProt Secondary Accession #
Q5JUY4; Q9BW56; Q9UQI9; B2R6Z6; D3DPJ1
UniProt Related Accession #
Q12834
GenBank Nucleotide #
NM_001255.2
NCBI Official Full Name
cell division cycle protein 20 homolog
NCBI Official Synonym Full Names
cell division cycle 20
NCBI Official Symbol
CDC20
NCBI Official Synonym Symbols
CDC20A; p55CDC; bA276H19.3
UniProt Protein Name
Cell division cycle protein 20 homolog
UniProt Synonym Protein Names
p55CDC
Protein Family
Anaphase-promoting complex
UniProt Gene Name
CDC20
UniProt Entry Name
CDC20_HUMAN
NCBI Protein Information
cell division cycle protein 20 homolog; cell division cycle 20 homolog; CDC20 cell division cycle 20 homolog

NCBI Summary for Cdc20

CDC20 appears to act as a regulatory protein interacting with several other proteins at multiple points in the cell cycle. It is required for two microtubule-dependent processes, nuclear movement prior to anaphase and chromosome separation. [provided by RefSeq, Jul 2008]

UniProt Comments for Cdc20

CDC20: Required for full ubiquitin ligase activity of the anaphase promoting complex/cyclosome (APC/C) and may confer substrate specificity upon the complex. Is regulated by MAD2L1: in metaphase the MAD2L1-CDC20-APC/C ternary complex is inactive and in anaphase the CDC20-APC/C binary complex is active in degrading substrates. The CDC20-APC/C complex positively regulates the formation of synaptic vesicle clustering at active zone to the presynaptic membrane in postmitotic neurons. CDC20-APC/C-induced degradation of NEUROD2 induces presynaptic differentiation. Found in a complex with CDC20, CDC27, SPATC1 and TUBG1. Interacts with SPATC1. Interacts with NEUROD2. Interacts with MAD2L1 and BUB1B. The phosphorylated form interacts with APC/C. Interacts with NINL. May interact with MAD2L2. Interacts with CDK5RAP2. Interacts with isoform 1 of NEK2. Belongs to the WD repeat CDC20/Fizzy family.

Protein type: Ubiquitin conjugating system; Cell cycle regulation

Chromosomal Location of Human Ortholog: 1p34.1

Cellular Component: nucleoplasm; spindle pole; centrosome; anaphase-promoting complex; perinuclear region of cytoplasm; cytoplasm; spindle; cytosol; nucleus

Molecular Function: protein C-terminus binding; protein binding; enzyme binding

Biological Process: positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle; mitosis; negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle; positive regulation of synaptic plasticity; regulation of meiosis; regulation of dendrite development; protein ubiquitination; cell cycle; anaphase-promoting complex activation; regulation of ubiquitin-protein ligase activity during mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; positive regulation of cell proliferation; mitotic cell cycle spindle assembly checkpoint; mitotic cell cycle
Show more

Research Articles on Cdc20

1. Nek2A binds with high affinity to apo-APC/C and is degraded by the pool of Cdc20 that avoids inhibition by the spindle assembly checkpoint.

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with anti-Cdc20 antibody

 Reference Product  PubMed Publications
 MAD2L1 antibody  >82 publications with Cdc20 and MAD2L1
 CCNB1 antibody  >82 publications with Cdc20 and CCNB1
 BUB1 antibody  >77 publications with Cdc20 and BUB1
 CDC27 antibody  >28 publications with Cdc20 and CDC27
 CDC16 antibody  >13 publications with Cdc20 and CDC16
 RASSF1 antibody  >9 publications with Cdc20 and RASSF1
 CCNA2 antibody  >8 publications with Cdc20 and CCNA2
 FBXO5 antibody  >7 publications with Cdc20 and FBXO5
 BUB1B antibody  >6 publications with Cdc20 and BUB1B
 AURKA antibody  >2 publications with Cdc20 and AURKA

Pathways associated with anti-Cdc20 antibody

 Products by Pathway  Pathway Diagram
 APC/C Complex Pathway antibodies  APC/C Complex Pathway Diagram
 APC/C Complex Pathway antibodies  APC/C Complex Pathway Diagram
 APC/C-mediated Degradation Of Cell Cycle Proteins Pathway antibodies  APC/C-mediated Degradation Of Cell Cycle Proteins Pathway Diagram
 APC/C:Cdc20 Mediated Degradation Of Cyclin B Pathway antibodies  APC/C:Cdc20 Mediated Degradation Of Cyclin B Pathway Diagram
 APC/C:Cdc20 Mediated Degradation Of Securin Pathway antibodies  APC/C:Cdc20 Mediated Degradation Of Securin Pathway Diagram
 APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins Pathway antibodies  APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins Pathway Diagram
 APC/C:Cdh1 Mediated Degradation Of Cdc20 And Other APC/C:Cdh1 Targeted Proteins In Late Mitosis/early G1 Pathway antibodies  APC/C:Cdh1 Mediated Degradation Of Cdc20 And Other APC/C:Cdh1 Targeted Proteins In Late Mitosis/early G1 Pathway Diagram
 Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins Pathway antibodies  Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins Pathway Diagram
 Adaptive Immune System Pathway antibodies  Adaptive Immune System Pathway Diagram
 Antigen Processing: Ubiquitination & Proteasome Degradation Pathway antibodies  Antigen Processing: Ubiquitination & Proteasome Degradation Pathway Diagram

Diseases associated with anti-Cdc20 antibody

 Disease Name  Pubmed Publications
 Neoplasms Antibodies  >87 publications with Cdc20 and Neoplasms
 Carcinoma Antibodies  >26 publications with Cdc20 and Carcinoma
 Cell Transformation, Neoplastic Antibodies  >15 publications with Cdc20 and Cell Transformation, Neoplastic
 Breast Neoplasms Antibodies  >13 publications with Cdc20 and Breast Neoplasms
 Adenocarcinoma Antibodies  >11 publications with Cdc20 and Adenocarcinoma
 Lung Neoplasms Antibodies  >10 publications with Cdc20 and Lung Neoplasms
 Neoplasms, Experimental Antibodies  >9 publications with Cdc20 and Neoplasms, Experimental
 Disease Models, Animal Antibodies  >7 publications with Cdc20 and Disease Models, Animal
 Drug Toxicity Antibodies  >6 publications with Cdc20 and Drug Toxicity
 Prostatic Neoplasms Antibodies  >6 publications with Cdc20 and Prostatic Neoplasms

Organs/Tissues associated with anti-Cdc20 antibody

 Organ/Tissue Name  Pubmed Publications
 Brain Antibodies  >20 publications with Cdc20 and Brain
 Liver Antibodies  >16 publications with Cdc20 and Liver
 Lung Antibodies  >14 publications with Cdc20 and Lung
 Blood Antibodies  >11 publications with Cdc20 and Blood
 Prostate Antibodies  >9 publications with Cdc20 and Prostate
 Bone Antibodies  >6 publications with Cdc20 and Bone
 Nerve Antibodies  >5 publications with Cdc20 and Nerve
 Muscle Antibodies  >5 publications with Cdc20 and Muscle
 Embryonic Tissue Antibodies  >4 publications with Cdc20 and Embryonic Tissue
 Bone Marrow Antibodies  >4 publications with Cdc20 and Bone Marrow
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000